Perspectives of b-mode transcranial ultrasound

NeuroImage

Volumn 15, Issue 3, 2002, Pages 463-473

  Berg, Daniela ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BRAIN DISEASE; BRAIN REGION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; DYSTONIA; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RELIABILITY; REVIEW; SIGNAL DETECTION; TRANSCRANIAL COLOR CODED SONOGRAPHY; TREATMENT INDICATION;

EID: 0036334723     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.2001.1014     Document Type: Article

References (98)

1. Noninvasive transcranial ultrasound recording of flow velocity in basal cerebral arteries
2. T2 relaxation time in patients with Parkinson's disease
3. Comparative study of power-based versus mean frequency-based transcranial color-coded duplex sonography in normal adults
4. Contrast-ehanced transcranial colo-coded duplex sonography in ischemic cerebrovascular disease
5. Assessment of 50 and <50 per cent intracranial stenoses by transcranial color-coded duplex sonography
6. Aneurysms and arteriovenous malformations (AVMs)
7. Ventricular enlargement and caudate hyperdensity in elderly depressives
8. Pathological findings in neuropsychiatric diseases
9. Reduced echogenicity of the brainstem raphe specific to unipolar depression: A transcranial color-coded realtime sonography study
10. Basal limbic system alteration in major depression: A hypothesis supported by transcranial sonography and MRI findings
11. Increased tissue copper and manganese content in primary adult-onset dystonia
12. Identification of ventricular enlargement and estimation of ventricular pressure by transcranial colo-coded real-time sonography
13. Examination techniques
14. Postoperative neuroimaging of high grade gliomas: Comparison of transcranial sonography, MRI and CT
15. Reliability of transcranial colour-coded real-time sonography in the assessment of brain tumors: Correlation between ultrasound, computerized tomography and biopsy findings
16. Preoperative and postoperative follow-up in brain tumors: Comparison of transcranial color-coded real-time sonography and computed tomography findings
17. Comparison of transcranial sonography, MRI, and SPECT findings in idiopathic spasmodic torticollis
18. Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations
19. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranlal color-coded real-time sonography
20. Echogenicity of the brainstem raphe in patients with major depression
21. Imaging of cerebral arteriovenous malformations by transcranial color-coded real-time sonography
22. Die transkranielle farbkodierte real-time sonographie des erwachsenen. Teil 1: Normalbefunde und zerebrovaskuläre Ischämien
23. Die transkranielle farbkodierte real-time sonographie des erwachsenen. Teil 2: Zerebrale blutungen und tumoren
24. Parkinson's disease and depression: Evidence for an alteration of the basal limbic system detected by transcranial sonography
25. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
26. Iron accumulation of the substantia nigra in rats visualized by ultrasound
27. The basal ganglia in haemochromatosis
28. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy
29. Ventricular size measurement by transcranial ultrasound correlates with clinical disability and cognitive dysfunction in patients with multiple sclerosis
30. Echogenidty of the substantia nigra - Marker for an increased iron content and susceptibility to nigrostriatal injury
31. Echogenicity of the substanita nigra in Parkinson's disease and its relation to clinical findings
32. Relationship of substantia nigra echogenicity and motor function in elderly subjects
33. Depression in Parkinson's disease: Brainstem midline alteration on transcranial sonography and magnetic resonance imaging
34. Lesion pattern in patients with multiple sclerosis and depression
35. Changes of copper transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia
36. Sonographic examination of the adult brain
37. Differing patterns of striatal [18F]-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
38. Motor reorganization in acquired hemidystonia
39. Depression and Parkinson's Disease: A review
40. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia
41. Blood flow velocity and vasomotor reactivitz in patients with arteriovenous malformations. A transcranial Doppler study
42. The neurobiological substrates of depression in Parkinson's disease
43. New evolution of transcranial tomography (TCT) and transcranial color coded Doppler tomography (TCDT)
44. Historical development of transcranial color-coded tomography
45. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
46. Diagnostic impact and prognostic relevance of early contrast-enhanced transcranial color-coded duplex sonography in acute stroke
47. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression
48. Dopamine D2 receptor imaging with iodine-123-iodobenzamine SPECT in idiopathic rotational torticollis
49. MRI of corpus callosum and septum pellucidum in depression
50. A magnetic resonance imaging study of putamen nuclei in major depression
51. Single photon emission computed tomographic imaging demonstrating loss of striatal dopamine transporters in Parkinson's disease
52. Coparative nigrostriatal dopaminergic imaging with iodine-123 beta-CIT-FP/SPECT and fluorine-18 FDOPA/PET
53. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique
54. The role of iron in neurodegeneration
55. Current status of transcranial color duplex ultrasound in the adult
56. Transcranial color-coded duplex sonography in cerebral arteriovenous malformations
57. Neuroanatomical substrates of depression in the elderly
58. Pre- and intraoperative transcranial color-coded real-time sonography in stereotactic biopsies of midline tumors
59. Reduction of Menkes mRNA and copper in leukocytes of patients with primary adult-onset dystonia
60. Surgical anatomy of the brainstem
61. Brain dopamine system studied in patients with dystonia using positron emission tomography
62. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease
63. Early postoperative transcranial sonography (TCS), CT, and MRI after resection of high grade glioma: Evaluation of residual tumour and its influence on prognosis
64. Sonographic findings in acute stroke
65. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease
66. Clinical and biochemical features of depression in Parkinson's disease
67. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease
68. Use of transcranial real-time ultrasonography for praogramming a shunt valve system
69. Bedside measurement of the third ventricle's diameter during episodes of arising intracranial pressure after head trauma. Using transcranial real-time sonography for a non-invasive examination of intracranial compensation mechanisms
70. Potential limitations of echo-contrast-enhanced ultrasonography in acute stroke patients
71. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography
72. Magnetic resonance imaging in parkinsonism
73. The neuropathologic basis of different clinical subgroups of Parkinson's disease
74. Decreased [18F]spiperone binding in putamen in dystonia
75. PET studies of the striatal dopaminergic system in Parkinson's disease (PD)
76. Increased activation of frontal areas during arm movement in idiopathic torsion dystonia
77. Contrast-enhanced transcranial color-coded real-time sonography: A reliable tool for the diagnosis of middle cerebral artery trunk occlusion in patients with insufficient temporal bone window
78. Second harmonic imaging in acute middle cerebral artery infarction. Preliminary results
79. Contrast agent specifc imaging modes for the ultrasonic assessment of parenchyreal cerebral echo contrast enhancement
80. Cerebral arteriovenous transit time (cTT): A sonographic assessment of cerebral microcirculation using ultrasound contrast agents
81. Diagnostic impact of cerebral transit-time (cTT) in the identification of microangiopathy in dementia: A transcranial ultrasound study
82. Cortical magnetic resonance imaging changes in elderly patients with major depression
83. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
84. Depression in Parkinson's disease. A positron emission study
85. 2 times of the lentifrom nucleus in idiopathic spasmodic torticollis
86. Transkranielle real-time-sonographie bei kindern und jugendlichen. Uttraschallanatomie des gehirns
87. Comparative study of transcranial color duplex sonography and transcranial Doppler sonography in adults
88. Harmonic imaging of the human brain. Visualization of brain perfusion with ultrasound
89. Transcranial color-coded duplex sonography of intracerebral hematomas in adults
90. Potential and limitations of transcranial color-coded sonography in stroke patients
91. Evaluation of the ventricular system in adults by transcranial duplex sonography
92. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
93. Uttrasonographic diagnosis of brain tumors in infancy
94. Transcranial sonography: Integration into target volume definition for glioblastoma multiforme
95. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance
96. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease